Algert Global LLC Karyopharm Therapeutics Inc. Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.84 - $3.92 $11,771 - $16,248	4,145 Added 5.01%	86,813 $338,000
Q4 2022 Feb 13, 2023	SELL	$2.48 - $5.93 $32,959 - $78,809	-13,290 Reduced 13.85%	82,668 $281,000
Q3 2022 Nov 15, 2022	SELL	$4.08 - $5.82 $186,178 - $265,578	-45,632 Reduced 32.23%	95,958 $524,000
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $587,598 - $1.19 Million	141,590 New	141,590 $639,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $462,392 - $1.13 Million	-78,239 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $48,453 - $80,073	-9,300 Reduced 10.62%	78,239 $503,000
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $227,924 - $544,457	51,219 Added 141.02%	87,539 $509,000
Q2 2021 Aug 13, 2021	BUY	$8.11 - $11.11 $294,555 - $403,515	36,320 New	36,320 $375,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $53.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.